OBJECTIVE: Trichothiodystrophy (TTD) is a rare, autosomal recessive disorder characterized by sulfur-deficient brittle hair and multisystem abnormalities. Many TTD patients have a defect in known DNA repair genes. This report systematically evaluates the ocular manifestations of the largest-to-date cohort of TTD patients and xeroderma pigmentosum (XP)/TTD patients. DESIGN: Case series. PARTICIPANTS: Thirty-two participants, ages 1 to 30 years, referred to the National Eye Institute for examination from 2001 to 2010; 25 had TTD and 7 had XP/TTD. METHODS: Complete, age- and developmental stage-appropriate ophthalmic examination. MAIN OUTCOME MEASURES: Visual acuity (VA), best-corrected VA, ocular motility, state of the ocular surface and corneal endothelial cell density, corneal diameter, and lens assessment. RESULTS: Developmental abnormalities included microcornea (44% TTD), microphthalmia (8% TTD, 14% XP/TTD), nystagmus (40% TTD), and infantile cataracts (56% TTD, 86% XP/TTD). Corrective lenses were required by 65% of the participants, and decreased best-corrected VA was present in 28% of TTD patients and 71% of XP/TTD patients. Degenerative changes included dry eye (32% TTD, 57% XP/TTD) and ocular surface disease identified by ocular surface staining with fluorescein (32% TTD) that usually are exhibited by much older patients in the general population. The 2 oldest TTD patients exhibited clinical signs of retinal/macular degeneration. Four XP/TTD patients presented with corneal neovascularization. CONCLUSIONS: These TTD and XP/TTD study participants had a wide variety of ocular findings including refractive error, infantile cataracts, microcornea, nystagmus, and dry eye/ocular surface disease. Although many of these can be ascribed to abnormal development--likely owing to abnormalities in basal transcription of critical genes--patients may also have a degenerative course. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosures may be found after the references.
OBJECTIVE: Trichothiodystrophy (TTD) is a rare, autosomal recessive disorder characterized by sulfur-deficient brittle hair and multisystem abnormalities. Many TTDpatients have a defect in known DNA repair genes. This report systematically evaluates the ocular manifestations of the largest-to-date cohort of TTDpatients and xeroderma pigmentosum (XP)/TTDpatients. DESIGN: Case series. PARTICIPANTS: Thirty-two participants, ages 1 to 30 years, referred to the National Eye Institute for examination from 2001 to 2010; 25 had TTD and 7 had XP/TTD. METHODS: Complete, age- and developmental stage-appropriate ophthalmic examination. MAIN OUTCOME MEASURES: Visual acuity (VA), best-corrected VA, ocular motility, state of the ocular surface and corneal endothelial cell density, corneal diameter, and lens assessment. RESULTS:Developmental abnormalities included microcornea (44% TTD), microphthalmia (8% TTD, 14% XP/TTD), nystagmus (40% TTD), and infantile cataracts (56% TTD, 86% XP/TTD). Corrective lenses were required by 65% of the participants, and decreased best-corrected VA was present in 28% of TTDpatients and 71% of XP/TTDpatients. Degenerative changes included dry eye (32% TTD, 57% XP/TTD) and ocular surface disease identified by ocular surface staining with fluorescein (32% TTD) that usually are exhibited by much older patients in the general population. The 2 oldest TTDpatients exhibited clinical signs of retinal/macular degeneration. Four XP/TTDpatients presented with corneal neovascularization. CONCLUSIONS: These TTD and XP/TTD study participants had a wide variety of ocular findings including refractive error, infantile cataracts, microcornea, nystagmus, and dry eye/ocular surface disease. Although many of these can be ascribed to abnormal development--likely owing to abnormalities in basal transcription of critical genes--patients may also have a degenerative course. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosures may be found after the references.
Authors: Jan de Boer; Jaan Olle Andressoo; Jan de Wit; Jan Huijmans; Rudolph B Beems; Harry van Steeg; Geert Weeda; Gijsbertus T J van der Horst; Wibeke van Leeuwen; Axel P N Themmen; Morteza Meradji; Jan H J Hoeijmakers Journal: Science Date: 2002-04-11 Impact factor: 47.728
Authors: Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer Journal: J Med Genet Date: 2010-11-19 Impact factor: 6.318
Authors: John Paul SanGiovanni; Emily Y Chew; George F Reed; Nancy A Remaley; J Bronwyn Bateman; Tina A Sugimoto; Mark A Klebanoff Journal: Arch Ophthalmol Date: 2002-11
Authors: B C Broughton; M Berneburg; H Fawcett; E M Taylor; C F Arlett; T Nardo; M Stefanini; E Menefee; V H Price; S Queille; A Sarasin; E Bohnert; J Krutmann; R Davidson; K H Kraemer; A R Lehmann Journal: Hum Mol Genet Date: 2001-10-15 Impact factor: 6.150
Authors: Brian P Brooks; Amy H Thompson; Rachel J Bishop; Janine A Clayton; Chi-Chao Chan; Ekaterini T Tsilou; Wadih M Zein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Nicholas T Iliff; Porcia Bradford; John J Digiovanna; Kenneth H Kraemer Journal: Ophthalmology Date: 2013-04-16 Impact factor: 12.079
Authors: Mariam B Totonchy; Deborah Tamura; Matthew S Pantell; Christopher Zalewski; Porcia T Bradford; Saumil N Merchant; Joseph Nadol; Sikandar G Khan; Raphael Schiffmann; Tyler Mark Pierson; Edythe Wiggs; Andrew J Griffith; John J DiGiovanna; Kenneth H Kraemer; Carmen C Brewer Journal: Brain Date: 2013-01 Impact factor: 13.501
Authors: Louise F Porter; Neil Saptarshi; Yongxiang Fang; Sonika Rathi; Anneke I den Hollander; Eiko K de Jong; Simon J Clark; Paul N Bishop; Timothy W Olsen; Triantafillos Liloglou; Venkata R M Chavali; Luminita Paraoan Journal: Clin Epigenetics Date: 2019-01-14 Impact factor: 6.551